We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.35B
AUM Growth
+$25.5M
Cap. Flow
+$32.7M
Cap. Flow %
2.42%
Top 10 Hldgs %
12.05%
Holding
2,121
New
584
Increased
441
Reduced
528
Closed
563

Top Sells

Rank Stock Value
1
LMND icon
Lemonade
LMND
+$4.64M
2
MGNI icon
Magnite
MGNI
+$3.66M
3
RELY icon
Remitly
RELY
+$3.66M
4
MNRO icon
Monro
MNRO
+$3.65M
5
VGR
Vector Group Ltd.
VGR
+$3.32M

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Healthcare 13.13%
3 Financials 12.64%
4 Consumer Discretionary 12.16%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BB icon
1451
BlackBerry
BB
$5.26B
$170K 0.01%
44,921
-120,473
-73% -$320K
CHRS icon
1452
Coherus Oncology
CHRS
$196M
$170K 0.01%
+123,022
New +$138K
XERS icon
1453
Xeris Biopharma Holdings
XERS
$1.45B
$169K 0.01%
49,843
+22,493
+82% +$72.4K
GPGI
1454
GPGI Inc
GPGI
$4.35B
$168K 0.01%
13,187
-66,182
-83% -$838K
INTT icon
1455
inTEST
INTT
$177M
$168K 0.01%
+19,595
New +$148K
UPLD icon
1456
Upland Software
UPLD
$15.4M
$167K 0.01%
+3,856
New +$125K
OABI icon
1457
OmniAb
OABI
$447M
$166K 0.01%
46,899
-44,538
-49% -$176K
SHIP icon
1458
Seanergy Maritime Holdings
SHIP
$365M
$164K 0.01%
+23,614
New +$212K
CUE icon
1459
Cue Biopharma
CUE
$114M
$163K 0.01%
4,993
-4,729
-49% -$178K
PXLW icon
1460
Pixelworks
PXLW
$41.6M
$154K 0.01%
17,578
+6,858
+64% +$62.2K
RPTX
1461
DELISTED
Repare Therapeutics
RPTX
$154K 0.01%
117,296
-123,226
-51% -$367K
CION icon
1462
CION Investment
CION
$374M
$153K 0.01%
13,384
-6,472
-33% -$75.5K
HE icon
1463
Hawaiian Electric Industries
HE
$2.14B
$153K 0.01%
+15,773
New +$159K
INVX
1464
Innovex International
INVX
$1.97B
$153K 0.01%
10,948
+906
+9% +$13.6K
TUYA
1465
Tuya Inc
TUYA
$1.1B
$151K 0.01%
84,397
+73,051
+644% +$123K
AURA icon
1466
Aura Biosciences
AURA
$826M
$150K 0.01%
+18,277
New +$172K
DIBS icon
1467
1stdibs.com
DIBS
$171M
$150K 0.01%
42,388
-45,538
-52% -$184K
AMCR icon
1468
Amcor
AMCR
$22.1B
$149K 0.01%
3,177
-3,661
-54% -$191K
CLBR
1469
DELISTED
Colombier Acquisition Corp II
CLBR
$149K 0.01%
+12,658
New +$136K
INSG icon
1470
Inseego
INSG
$90.5M
$149K 0.01%
+14,560
New +$214K
TERN
1471
DELISTED
Terns Pharmaceuticals
TERN
$149K 0.01%
+26,940
New +$182K
TLYS icon
1472
Tilly's
TLYS
$128M
$149K 0.01%
34,974
-23,256
-40% -$94.9K
GRAB icon
1473
Grab
GRAB
$14.9B
$148K 0.01%
+31,400
New +$143K
OLMA icon
1474
Olema Pharmaceuticals
OLMA
$1.05B
$147K 0.01%
+25,268
New +$252K
CHMI
1475
Cherry Hill Mortgage Investment Corp
CHMI
$88.5M
$146K 0.01%
55,115
-154,215
-74% -$463K

Similar funds

GSA Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, GSA Capital Partners held 2,121 positions worth $1.35B, up 1.9% from $1.32B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners's Q4 2024 filing shows 584 new, 441 increased, 528 reduced and 563 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M. The largest sale was Lemonade, an estimated $4.64M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • GSA Capital Partners's largest Q4 2024 buy was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M.
  • GSA Capital Partners added most to Frontline in Q4 2024, an estimated $5.7M increase.
  • GSA Capital Partners's biggest Q4 2024 reduction was Lemonade, cutting an estimated $4.64M.
  • GSA Capital Partners fully exited Monro in Q4 2024, selling an estimated $3.65M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.35B portfolio in Q4 2024.
  • GSA Capital Partners opened 584 new positions and closed 563 in Q4 2024.
  • GSA Capital Partners's portfolio value rose 1.9% quarter-over-quarter to $1.35B.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.